Trial Details
RECRUITINGBasic Information
| Clinical ID | c1726 |
|---|---|
| Identifier | NCT05092269 |
| Trial Title | A Long-term Extension Study of Ustekinumab in Pediatric Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative|Arthritis, Psoriatic |
| Interventions | DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Atlanta |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-10-18 |
|---|---|
| Primary Completion Date | 2027-09-29 |
| Completion Date | 2027-09-29 |